Hyrimoz 61314-0476

Generic: Adalimumab-Adaz

Product NDC

61314-0476

Manufacturer: Sandoz Inc
Dosage Form: Injection, Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: July 1, 2023
Listing Expires: December 31, 2027
Application: BLA761071

Need to source Hyrimoz? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Adalimumab	20 mg/.2mL

Drug Class

Tumor Necrosis Factor Blocker [EPC]AntibodiesMonoclonal [CS]

Packaging Options(1)

61314-0476-64

2 SYRINGE, GLASS in 1 CARTON (61314-476-64) / .2 mL in 1 SYRINGE, GLASS

View →